SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-022731
Filing Date
2023-06-20
Accepted
2023-06-20 17:02:40
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687294950.html 4  
1 FORM 4 wk-form4_1687294950.xml 4 3630
  Complete submission text file 0001628280-23-022731.txt   5255
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9220 KIRBY DRIVE SUITE 500 HOUSTON TX 77054
Business Address
TANNENBAUM RENEE P (Reporting) CIK: 0001543174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 231026109